Phytomedicine · 2026 Huangjin Shuangshen Jiawei decoction alleviated coronary heart disease comorbid with depression partly through gut microbiota-mediated regulation of the SRSF1-p53-ASPP1 signaling axis. Jia R, Wang Y, Wang J, et al. Faecalibacterium prausnitzii PubMed ↗
BMC medicine · 2026 Circulating imidazole propionate and coronary heart disease risk: interplay between histidine intake, fiber, and gut microbiome. Liang X, Zhu L, Li J, et al. Blautia PubMed ↗
Journal of cardiovascular pharmacology · 2026 Role of the Gut Microbiome in Modulating Interactions Between β-Lactam Antibiotics and Statins in Coronary Heart Disease. Wang G, Luo Y, Song S, et al. Faecalibacterium PubMed ↗
Nutrients · 2024 Lactiplantibacillus plantarum P470 Isolated from Fermented Chinese Chives Has the Potential to Improve In Vitro the Intestinal Microbiota and Biological Activity in Feces of Coronary Heart Disease (CHD) Patients. Yang L, Wu Y, Yang J, et al. Lactiplantibacillus plantarumBacteroides PubMed ↗
Probiotics and antimicrobial proteins · 2024 An In Vitro Evaluation of the Effect of Bifidobacterium longum L556 on Microbiota Composition and Metabolic Properties in Patients with Coronary Heart Disease (CHD). Yang L, Wu Y, Zhao X, et al. Bifidobacterium longumFaecalibacterium PubMed ↗
Frontiers in cellular and infection microbiology · 2022 Regional pattern and signatures of gut microbiota in rural residents with coronary heart disease: A metagenomic analysis. Li W, Li H, Wang S, et al. Agathobacter rectalis PubMed ↗